Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Dier Mardi
Relationship:  
City:   South San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   101,126    

Indirect Shares

   875      
Direct Value   $4,772,148    

Indirect Value

   $3,710      
Total Shares   102,001      
Total Value   $4,775,858      


Adamas Pharmaceuticals Inc $82,200 Prelude Therapeutics Inc $0 Ultragenyx Pharmaceutical Inc $2,950,587 Acelyrin, Inc. $23,557 Madrigal Pharmaceuticals Inc $1,715,804 Adamas Pharmaceuticals Inc $82,200 Prelude Therapeutics Inc $0 Ultragenyx Pharmaceutical Inc $2,950,587 Acelyrin, Inc. $23,557 Madrigal Pharmaceuticals Inc $1,715,804
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    0   
    1    
     Stock price went down :
    2   
    0    
   
     Gain/Loss Ratio :
   -2.0   
   1.0   
     Percentage Gain/Loss :
   -71.0%
 18.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Portola Pharmaceuticals Inc PTLA EVP and CFO 2020-07-02 0 0    Premium*  
            Adamas Pharmaceuticals Inc ADMS Director 2021-06-02 10,000 2020-06-03 0    Premium*  
            Prelude Therapeutics Inc PRLD Director 2020-09-29 10,000 2020-09-29 0    Premium*  
            Ultragenyx Pharmaceutical Inc RARE CFO & Executive Vice P... 2022-10-14 66,695 2020-10-12 0    Premium*  
            Acelyrin, Inc. SLRN CFO and CBO 2023-05-09 5,556 2023-05-09 875    Premium*  
            Madrigal Pharmaceuticals Inc MDGL 2024-03-11 8,875 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
MDGL Madrigal Pharmaceuticals ... SVP and CFO   •       –      –    2024-03-11 3 IO $0.00 $0 D/D 0 8,875 %
SLRN Acelyrin, Inc. CFO and CBO   •       –      –    2023-05-09 4 B $18.00 $31,500 I/I 1,750 875 1.99 %
SLRN Acelyrin, Inc. CFO and CBO   •       –      –    2023-05-09 4 B $18.00 $100,008 D/D 5,556 5,556 2.74 %
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2022-10-14 4 AS $40.16 $65,421 D/D (1,629) 66,695 0 %
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2022-10-12 4 S $38.22 $133,158 D/D (3,484) 68,324 0 %
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2022-09-16 4 A $0.00 $0 D/D 20,000 71,808 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2022-03-03 4 AS $64.55 $27,111 D/D (420) 51,808 0 %
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2022-03-01 4 A $0.00 $0 D/D 14,000 52,228 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2022-03-01 4 AS $66.62 $35,575 D/D (534) 38,228 0 %
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2021-10-14 4 AS $81.16 $264,663 D/D (3,261) 38,762 0 %
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2021-10-12 4 AS $82.79 $287,861 D/D (3,477) 42,023 0 %
ADMS Adamas Pharmaceuticals In... Director   –       •      –    2021-06-02 4 A $0.00 $0 D/D 5,000 10,000 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2021-03-01 4 A $0.00 $0 D/D 5,500 45,500 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2020-10-12 4 A $0.00 $0 D/D 40,000 40,000 0 -
PRLD Prelude Therapeutics Inc Director   –       •      –    2020-09-29 4 B $19.00 $190,000 D/D 10,000 10,000 2.39 -
PTLA Portola Pharmaceuticals I... EVP and CFO   •       –      –    2020-07-02 4 D $18.00 $712,314 D/D (39,573) 0 0 -
PTLA Portola Pharmaceuticals I... EVP and CFO   •       –      –    2020-06-18 4 A $8.36 $84 D/D 10 10 0 -
ADMS Adamas Pharmaceuticals In... Director   –       •      –    2020-06-03 4 A $0.00 $0 D/D 5,000 5,000 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2020-03-02 4 D $9.68 $43,976 D/D (4,543) 78,229 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2020-02-03 4 D $12.89 $44,277 D/D (3,435) 81,533 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2020-01-31 4 A $0.00 $0 D/D 16,250 84,968 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2020-01-14 4 D $13.80 $17,623 D/D (1,277) 68,718 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2020-01-12 4 A $0.00 $0 D/D 2,125 69,995 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2019-05-20 4 D $28.69 $86,701 D/D (3,022) 69,570 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2019-05-19 4 A $0.00 $0 D/D 5,859 72,592 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us